Useful resources |
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors (Cochrane Review) ABSTRACT Background: In some people with haemophilia, therapeutic clotting agents are recognised as a foreign protein and anti-FVIII antibodies, known as 'inhibitors', are produced. This review investigates which treatment most effectively arrests acute bleeding in peopl . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |